Evidence map›Paper›PMID 38456412›Full record

ArticleJournal of the American Heart Association2024

Mendelian Randomization Study With Clinical Follow-Up Links Metabolites to Risk and Severity of Pulmonary Arterial Hypertension.

Elham Alhathli, Thomas Julian, Zain Ul Abideen Girach, A A Roger Thompson, Christopher Rhodes, Stefan Gräf, Niamh Errington, Martin R Wilkins, Allan Lawrie, Dennis Wang and 1 more

Open access · goldAbstract read
In one paragraph

Article in Journal of the American Heart Association, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
4.6field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 11 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. L-serine metabolic regulation and host respiratory homeostasis.Frontiers in cellular and infection microbiology · 2025
    Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 3 countries.

Elham AlhathliSheffield Institute for Translational Neuroscience (SITraN), University of Sheffield Sheffield UK.ORCID 0009-0008-2147-9715
Thomas JulianDivision of Evolution, Infection and Genomics, School of Biological Sciences The University of Manchester Manchester UK.ORCID 0000-0002-5488-5620
Zain Ul Abideen GirachSheffield Institute for Translational Neuroscience (SITraN), University of Sheffield Sheffield UK.
A A Roger ThompsonDepartment of Infection, Immunity and Cardiovascular Disease University of Sheffield Sheffield UK.ORCID 0000-0002-0717-4551
Christopher RhodesNational Heart and Lung Institute, Imperial College London London UK.ORCID 0000-0002-4962-3204
Stefan GräfDepartment of Respiratory Medicine University of Cambridge Cambridge UK.ORCID 0000-0002-1315-8873
Niamh ErringtonNational Heart and Lung Institute, Imperial College London London UK.ORCID 0000-0001-6768-7394
Martin R WilkinsNational Heart and Lung Institute, Imperial College London London UK.ORCID 0000-0003-3926-1171
Allan LawrieNational Heart and Lung Institute, Imperial College London London UK.ORCID 0000-0003-4192-9505
Dennis WangDepartment of Computer Science University of Sheffield Sheffield UK.ORCID 0000-0003-0068-1005
Johnathan Cooper-KnockSheffield Institute for Translational Neuroscience (SITraN), University of Sheffield Sheffield UK.ORCID 0000-0002-0873-8689
Imperial College London · GBUniversity of Sheffield · GBAgency for Science, Technology and Research · SGTaif University · SAUniversity of Cambridge · GBUniversity of Manchester · GB

Funding

Medical Research Council MR/K020919/1Wellcome Trust
6 · The paper itself

Abstract

backgroundPulmonary arterial hypertension (PAH) exhibits phenotypic heterogeneity and variable response to therapy. The metabolome has been implicated in the pathogenesis of PAH, but previous works have lacked power to implicate specific metabolites. Mendelian randomization (MR) is a method for causal inference between exposures and outcomes. METHODS AND

resultsUsing genome-wide association study summary statistics, we implemented MR analysis to test for potential causal relationships between serum concentration of 575 metabolites and PAH. Five metabolites were causally associated with the risk of PAH after multiple testing correction. Next, we measured serum concentration of candidate metabolites in an independent clinical cohort of 449 patients with PAH to check whether metabolite concentrations are correlated with markers of disease severity. Of the 5 candidates nominated by our MR work, serine was negatively associated and homostachydrine was positively associated with clinical severity of PAH via direct measurement in this independent clinical cohort. Finally we used conditional and orthogonal approaches to explore the biology underlying our lead metabolites. Rare variant burden testing was carried out using whole exome sequencing data from 578 PAH cases and 361 675 controls. Multivariable MR is an extension of MR that uses a single set of instrumental single-nucleotide polymorphisms to measure multiple exposures; multivariable MR is used to determine interdependence between the effects of different exposures on a single outcome. Rare variant analysis demonstrated that loss-of-function mutations within activating transcription factor 4, a transcription factor responsible for upregulation of serine synthesis under conditions of serine starvation, are associated with higher risk for PAH. Homostachydrine is a xenobiotic metabolite that is structurally related to l-proline betaine, which has previously been linked to modulation of inflammation and tissue remodeling in PAH. Our multivariable MR analysis suggests that the effect of l-proline betaine is actually mediated indirectly via homostachydrine.

conclusionsOur data present a method for study of the metabolome in the context of PAH, and suggests several candidates for further evaluation and translational research.

Indexed as

Pulmonary Arterial HypertensionFamilial Primary Pulmonary HypertensionFollow-Up StudiesGenome-Wide Association StudyHumansMendelian Randomization AnalysisSerineSerinehomostachydrineMendelian randomizationmetabolomepulmonary arterial hypertensionserine

Identifiers

PMID38456412
PMCPMC11010003
OpenAlexW4392587862

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.